Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 84 Recurrence 10 Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Mantle-Cell 5 Waldenstrom Macroglobulinemia 4 Neoplasms, Plasma Cell 3 Hematologic Neoplasms 3 Plasmacytoma 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Leukemia, Plasma Cell 2 Leukemia, Biphenotypic, Acute 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Amyloidosis 2 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Proteostasis Deficiencies 1 Plasmablastic Lymphoma 1 POEMS Syndrome 1 Neurofibrosarcoma 1

Interventions

Doxorubicin 10 Zidovudine 9 Vincristine 7 Bleomycin 7 Nivolumab 6 Liposomes 5 Interferon alpha-2 5 Etoposide 5 tecogalan 4 pembrolizumab 4 liposomal doxorubicin 4 Valganciclovir 4 Specimen Handling 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Magnetic Resonance Spectroscopy 4 pomalidomide 3 Ritonavir 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma, Kaposi × ixazomib × Clear all

NCT04305691 2026-02-27

Trial of Ixazomib for Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Recruiting

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡